VHL antibody
-
- Target See all VHL Antibodies
- VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This VHL antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Specificity
- Human VHL
- Purification
- Protein A/G purified
- Immunogen
-
Full length human recombinant protein of human VHL(NP_000542) produced in HEK293T cell.
Type of Immunogen: Recombinant protein - Clone
- 1E1
- Isotype
- IgG2b
- Top Product
- Discover our top product VHL Primary Antibody
-
-
- Application Notes
- Approved: IHC, IHC-P (1:150), WB (1:4000)
- Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
- Alternative Name
- VHL / Von Hippel Lindau (VHL Products)
- Background
-
Name/Gene ID: VHL
Synonyms: VHL, Elongin binding protein, HRCA1, RCA1, VHL1, Von Hippel-Lindau syndrome, Protein G7, PVHL - Gene ID
- 7428
- NCBI Accession
- NP_000542
- Pathways
- Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Ubiquitin Proteasome Pathway
-